中国P站

Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), refers to a range of persistent symptoms that continue for weeks or months after the acute phase of a COVID-19 infection has resolved. While the most widely recognized manifestations of Long COVID are related to fatigue, shortness of breath, and joint pain, neurological sequelae are also prominent and concerning. These include cognitive impairments, headaches, dizziness, sensory disturbances, and more severe conditions like strokes and encephalitis. As the pandemic continues, understanding the neurologic aspects of Long COVID is crucial for improving diagnosis, treatment, and recovery strategies [1,2].

Discussion

The exact mechanisms underlying Long COVID's neurological manifestations are not fully understood, but several theories have been proposed. One major hypothesis involves the persistence of viral particles in the brain or nervous system. Some studies suggest that the virus can invade neural tissue or linger in certain brain regions, triggering chronic inflammation. Another theory posits that Long COVID may involve an exaggerated immune response, such as a cytokine storm or autoimmunity, where the body’s immune system attacks its own tissues, including neurons and blood vessels in the brain [3-6].

Common neurological sequelae of Long COVID include:

Cognitive Dysfunction (Brain Fog): A hallmark of Long COVID, cognitive dysfunction can manifest as difficulty concentrating, memory problems, and mental fatigue. This condition, often referred to as "brain fog," is seen in a significant proportion of patients, particularly those who experienced severe or prolonged COVID-19 infections. Functional imaging studies have shown changes in areas of the brain responsible for memory, attention, and executive functions, which may explain these cognitive impairments [7,8].

Headaches and Migraines: Chronic headaches are a prevalent symptom in Long COVID patients, and studies have shown that some individuals experience migraines with an increased frequency post-infection. These headaches may be related to the inflammatory processes, vascular changes, or alterations in neural pathways that occur after COVID-19 infection.

Dizziness and Vertigo: Persistent dizziness, vertigo, and balance issues are common among those with Long COVID. These symptoms may be caused by vestibular dysfunction, a result of inflammation affecting the brainstem or inner ear structures [9,10].

Sensory Disturbances: Many patients report lingering sensory issues such as numbness, tingling, and hypersensitivity. These symptoms may stem from nerve damage or inflammation in peripheral nerves and the central nervous system.

Conclusion

The neurologic sequelae of Long COVID represent a significant burden on patients and healthcare systems alike. Cognitive dysfunction, headaches, dizziness, and more severe neurological complications are not only physically debilitating but can severely affect a person’s quality of life. Early diagnosis and intervention are key to mitigating the long-term impacts, and further research is needed to unravel the exact mechanisms of these symptoms. Understanding the neurologic consequences of Long COVID will be crucial for developing targeted therapies, improving patient outcomes, and providing long-term care to those affected by this evolving condition. As the world continues to cope with the aftermath of the COVID-19 pandemic, addressing Long COVID’s neurological effects will remain a priority for both researchers and healthcare providers.

References

1. Psychiatric Association (2013) . Arlington, VA: American Psychiatric Publishing.

   Google Scholar, Cross Ref

2. Autism Speaks (n.d.) .

   Google Scholar, Cross Ref

3. Batista I C, Gandolfi L, Nobrega Y K, Almeida R C, Almeida L M et al. (2012) . Arq Neuropsiquiatr 70: 28-33.

   , ,

4. Bragge A and Fenner P (2009) The emergence of the ‘Interactive Square’ as an approach to art therapy with children on the autistic spectrum. Int J Art Ther 14: 17-28.

   Indexed at, ,

5. Case C (2010) . ATOL: Art Therapy Online1: 1-28.

   , ,

6. Corbett B A, Schupp C W, Simon D, Ryan N and Mendoza S (2010). . Mol Autism 1: 13.

   , ,

7. Corbett BA, Key AP, QuallsL, Fecteau S, Newsom C et al (2016) . J Autism Dev Disord 46 : 658-672.

   , ,

8. D’Amico M and Lalonde C (2017) . Am J Art Ther 34: 176-182.

   , ,

9. DeMyer MK, Barton S, DeMyer WE, Norton JA, Allen J et al (1973). J Autism Child Schizophr 3: 199-246.

   , ,

10. Dominick KC, Davis NO, Lainhart J, Tager-Flusberg H and Folstein S (2007) . Res Dev Disabil 28: 145-162.

    , ,